Dalian Medical University
2 clinical trials · Sponsor
◉ Watch Dalian Medical University
| Record | Firm | Date |
|---|---|---|
| Linperlisib Plus Obinutuzumab and Venetoclax for Relapsed and Refractory Blastoid Variant of Mantle Cell Lymphoma. (NCT06324994) | Dalian Medical University | 2024-05-01 |
| Construction of a Predictive Model of Gangrenous Cholecystitis Based on Machine Learning (NCT06399081) | Dalian Medical University | 2023-12-01 |
Track Dalian Medical University automatically
Every clearance here is in the API, with alerts when new ones post.